Metrics as of 10/15/2026, 06:16 AM (Berlin time), refresh in progress.
Tempus AI Stock
Tempus AI, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Eric Lefkofsky
- Employees
- 3,800
- Market cap
- $12 B
- IPO
- 14/06/2024
Tempus AI, Inc. is a healthcare technology company based in Chicago, United States. Founded in 2015, the company operates the Tempus platform, which provides closed-loop, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Tempus AI stock: price history
1D
+0.1%
1W
-2.9%
1M
+9.8%
6M
+21.1%
YTD
+15.7%
1Y
-24.0%
2Y
+34.7%
5Y
–
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~23% stronger price swings than usual
Ask the agents about Tempus AI
Analyst assessment of Tempus AI
PRICE TARGET LOW
US$50.00
CONSENSUS
US$72.60
MEDIAN
US$72.50
PRICE TARGET HIGH
US$92.00
0
STRONG BUY
9
BUY
5
HOLD
0
SELL
0
STRONG SELL
14
TOTAL · Buy
As of: 12/10/2026
Tempus AI stock metrics
P/E
-47.78
P/B
27.63
EV/EBITDA
-140.96
RETURN ON EQUITY
1.3%
NET MARGIN
1.5%
DEBT/EQUITY
3.25
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
60.8%
FLOAT SHARES
106,501,144
AVG. DAILY VOLUME (30D)
6,998,750
Insider transactions (SEC)
Schoenherr Thomas Edward
LEFKOFSKY ERIC P
LEFKOFSKY ERIC P
LEFKOFSKY ERIC P
LEFKOFSKY ERIC P
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.1%
Forums (Reddit)
See the full forum history with Pro.
Institutional holders
Comparable stocks
Frequently asked questions about Tempus AI stock
What does Tempus AI do?
Tempus AI, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Eric Lefkofsky, the company employs around 3,800 people.
The IPO was on 14/06/2024; the stock trades on NASDAQ under the ticker TEM.
What do analysts say about Tempus AI stock?
14 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$72.60, ranging from US$50.00 to US$92.00, with a median of US$72.50.
This is an external assessment, not a statement by Market Jury.
When does Tempus AI report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 23% stronger than usual.
Does Tempus AI pay a dividend?
No, Tempus AI currently does not pay a dividend.
Which stocks are comparable to Tempus AI?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Tempus AI stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tempus AI against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.